Cucević I, Cucević B, Roglić M, Pongrac I
Klinika za plućne bolesti Jordanovac, Zagreb.
Plucne Bolesti. 1990 Jul-Dec;42(3-4):191-3.
A study of 970 patients treated for bronchogenic carcinoma (operation, cytostatic therapy, irradiation) reveal that only 122 (12.5%) were evaluated by the bronchoscopy. Among 47 (38.5%) out of 122 patients recidivation was confirmed (cytology or histology). The efficacy of radiology and sputum cytology is poor. Only 22/47 (47%) had radiologic evidence of recidivation and 18/47 (38%) had positive sputum cytology. Radiology and sputum cytology reveal recidivation in 27/47 (57%) patients. It means that bronchoscopy is the method of choice in the posttherapeutic monitoring of patients with bronchogenic carcinoma.
一项针对970例接受支气管源性癌治疗（手术、细胞抑制疗法、放疗）的患者的研究显示，只有122例（12.5%）接受了支气管镜检查评估。在122例患者中的47例（38.5%）中证实有复发（细胞学或组织学检查）。放射学和痰细胞学的效果不佳。只有22/47（47%）有复发的放射学证据，18/47（38%）痰细胞学检查呈阳性。放射学和痰细胞学在27/47（57%）的患者中发现了复发。这意味着支气管镜检查是支气管源性癌患者治疗后监测的首选方法。
